OTCMKTS:TPIY Tianyin Pharmaceutical (TPIY) Stock Price, News & Analysis → Your 'AI Income Playbook' Awaits... (From The Oxford Club) (Ad) Free TPIY Stock Alerts $0.0001 +0.00 (+∞) (As of 07/15/2019) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0178Volume88,900 shsAverage Volume36,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tianyin Pharmaceutical alerts: Email Address Ad Eagle PublishingTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its kind in the U.S. It’s in a prime position to profit.For the full story, click here About Tianyin Pharmaceutical Stock (OTCMKTS:TPIY)Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.Read More TPIY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TPIY Stock News HeadlinesMarch 17, 2023 | wsj.comTasly Pharmaceutical Group Co. Ltd. AMarch 2, 2023 | uk.investing.comTianjin Chase Sun Pharmaceutical Co Ltd (300026)February 28, 2023 | wsj.comTianjin Chase Sun Pharmaceutical Co. Ltd.February 25, 2023 | seekingalpha.comArrowhead Pharmaceuticals Requires CautionFebruary 23, 2023 | uk.finance.yahoo.comA Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)February 23, 2023 | wsj.comTianjin Tianyao Pharmaceutical Co. Ltd.February 22, 2023 | morningstar.comTianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class SFebruary 18, 2023 | marketwatch.comRifampicin Market Analysis by Application like Tuberculosis, Leprosy, Legionnaire's Disease, Others)February 9, 2023 | marketwatch.comPermethrin Spray Market to Grow Exponentially Due to Rising DemandFebruary 8, 2023 | marketwatch.comDoxofylline Tablets Market is set to see Revolutionary growth in decadeFebruary 8, 2023 | marketwatch.comDactinomycin Market is anticipated to boost sales at a Impressive CAGRFebruary 1, 2023 | marketwatch.comCyclopentanone (Cas 120-92-3) Market : Future Growth with Technology and Current Trends 2023 to 2029January 23, 2023 | marketwatch.comMycophenolic Acid Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028January 20, 2023 | marketwatch.comDibucaine(Cinchocaine) API Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2029January 12, 2023 | msn.comSix types of Benylin and Nurofen for children among medicines in short supplySee More Headlines Receive TPIY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:TPIY Previous SymbolNYSEMKT:TPI CUSIPN/A CIK1362718 Webwww.tianyinpharma.com Phone00-86-028-8551-6696FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta54.39 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesGuo Qing JiangChairman, President & Chief Executive OfficerTao YangChief Operating OfficerLi Ying WangFinancial ControllerYing ZhangDirector-Human ResourcesKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors TPIY Stock Analysis - Frequently Asked Questions How have TPIY shares performed in 2024? Tianyin Pharmaceutical's stock was trading at $0.0001 on January 1st, 2024. Since then, TPIY shares have increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. What other stocks do shareholders of Tianyin Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include International Business Machines (IBM). How do I buy shares of Tianyin Pharmaceutical? Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TPIY) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tianyin Pharmaceutical Inc Co Please log in to your account or sign up in order to add this asset to your watchlist. Share Tianyin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.